SEGMENT REPORTING (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2025 USD ($) segment	Mar. 31, 2024 USD ($)
Segment Reporting
Number of reportable segments | segment	1
Stock-based compensation	$ 1,185	$ 4,200
Interest income	(871)	(1,435)
Consolidated net loss	$ 2,518	$ 23,186
Segment Reporting, Other Segment Item, Composition, Description	(a) Other segment items include rent and facilities related expenses.	(a) Other segment items include rent and facilities related expenses.
Life Science
Segment Reporting
Professional fees and services	$ 1,778	$ 1,638
Stock-based compensation	1,184	4,200
Employee costs	202	5,889
Other segment items	225	319
AV-101 clinical trials		7,195
Chemistry, manufacturing, and controls		5,380
Interest income	(871)	(1,435)
Consolidated net loss	$ 2,518	$ 23,186